Skip Navigation Links
Home
DoctorsExpand Doctors
Services
Clinic Policies
Insurance
Research
Appointment
Our Locations
Contact us
    Hospital Affiliations
Houston Northwest Medical Center
Methodist Willowbrook Hospital
Cy-Fair Medical Center
North Cypress Medical Center
Manuscripts, Abstracts and Textbook Chapter Publications of Dr. Kris Vivek
 
Manuscripts and Abstracts
1. Durairajan N, Parasuraman V, Venkatesan M, Vivekananthan K. “Clinical Presentation of Meckel’s Diverticulum”. South Indian Surgical Clinics, June 1988. 
2. Vivekananthan K. “A Study of Atrial Septal Defect - Prevalence of Associated Lesions, Clinical and 2-D Echocardiographic Correlation’s ”. Dissertation submitted and accepted by Dr. M.G.R. Medical University, Madras, India - April 1991.
3. Vivekananthan K, Vladutiu AO, Harjai KJ, Schnapp MA, Bhayana J, Ellis AK, Mehra MR. “Are Biochemical Indices of Acute Cardiac Injury Useful in Predicting Cardiac Allograft Rejection”. Transplantation (Supplement) 1998;65:232. 
4. Vivekananthan K, Uber PA, DeGruiter H, Solis S, Kapoor C, Dumas-Hicks D, Mehra MR. “A Randomized Controlled Comparison of the Efficacy and Safety of Pravastatin and Simvastatin in Heart Transplantation”. Transplantation (Supplement) 1998;65:235.
5. Harjai KJ, Scott L, Vivekananthan K, Nunez E, Edupuganti R, Mehra MR. “The Tei Index: A New Prognostic Index for Dilated Cardiomyopathy”. Circulation (Supplement) 1998;17:I-642.
6. Vivekananthan K, Yue R, Lavie CJ, Mehra MR, Milani RV. “Exercise Cardiopulmonary Parameters in Elderly Patients with Cardiomyopathy”. Louisiana ACC Chapter 1999.
7. Vivekananthan K, Kalapura T, Feng Z, Park MH, Scott RL, Mehra MR. “Can abnormalities of Ventricular Repolarization Predict Cardiac Allograft Rejection?” Louisiana ACC Chapter 1999.
8. Vivekananthan K, Yue R, Lavie CJ, Mehra MR, Milani RV. “Differences in Exercise Cardiopulmonary Prognostic Indices in Elderly with Ischemic versus Non-ischemic Cardiomyopathy”. Louisiana ACC Chapter 1999.
9. Silva JA, Nunez E, Vivekananthan K, Jain SP, Jenkins S, Collins TC, Ramee SR, White CJ. “Cardiogenic Shock Complicating Acute Myocardial Infarction: A Comparison of Primary Angioplasty Versus Primary Stenting in in-Hospital Outcomes”. J Am Coll Cardiol 1999;33:368A. 
10. Mehra MR, Vivekananthan K, Uber PA, DeGruiter H, Kapoor C, Solis S, Lavie CJ, Milani RV. “A Prospective Randomized Trial of the Immunomodulatory Role of Simvastatin and Pravastatin on Cardiac Allograft Rejection”. J Am Coll Cardiol 1999;33:205A.
11. Vivekananthan K, Silva JA, Shamaileh Q, Sabet S, Jenkins SJ, Ramee SR, White CJ, Collins TC. “Immediate and Long-term Outcome of Percutaneous Intervention of Internal Mammary Artery Grafts”. Am J Cardiol 1999;84:(supp)47P. 
12. Jain SP, Vivekananthan K, White CJ, Jenkins SJ, Collins TC, Ramee SR. “Clopidogrel Versus Ticlopidine for Prevention of Stent Thrombosis”. Louisiana ACC Chapter 1999. 
13. Vivekananthan K, Quintana H, Dali S, Lavie CJ, Grant AE, Mehra MR, Milani RV. “Heart Failure with Preserved Systolic Function in African Americans: The Role of Diabetes Mellitus and Obesity”. Circulation 2000;102:II-781.
14. Vivekananthan K, Yue R, Lavie CJ, Mehra MR, Milani RV. “Does Severe Obesity Have an Impact on Prognostic Indices of Exercise Cardiopulmonary Function in Patients with Non-Ischemic Cardiomyopathy”. CHF (Supplement) 2000;6:22.
15. Vivekananthan K, Dali S, Quintana H, Lavie CJ, Grant AE, Gilliland YE, Milani RV, Mehra MR. “Comparing and Contrasting Differences Between Men and Women with Isolated Diastolic Heart Failure”. CHF (Supplement) 2000;6:63.
16. Vivekananthan K, Samal A, Chilakamarri V, Jenkins SJ, Collins TJ, White CJ, Ramee SR. “Is Combined Intervention a Safe Alternative to Staged Intervention in Patients with Coronary Artery Disease and Renal Artery Stenosis?” J Am Coll Cardiol 2000;35:69A.
17. Jain SP, White CJ, Collins TC, Jenkins SJ, Vivekananthan K, Ramee SR. “Endoluminal Stenting for Abdominal Angina: An Alternative to Surgical Revascularization”. J Am Coll Cardiol 2000;35:22A.
18. Vivekananthan K, Kalapura T, Park MH, Scott RL, Milani RV, Mehra MR. “Can Combined Indices of Diastolic and Systolic Myocardial Performance Reliably Predict Cardiac Allograft Rejection?” J Am Coll Cardiol 2000;35:221A.
19. Riaz A, Vivekananthan K. "Acute Myocardial Infarction in a Patient with Coronary Arterio Venous Fistula - An Extreme Case of Coronary Steal Syndrome". Louisiana ACP Chapter 2001.
20. Mulumudi M, Vivekananthan K. “Mysteries of mitral valve prolapse. Proper treatment requires consideration of all clues” Postgrad Med. 2001 Aug;110(2):43-4, 47-8, 53-4.
21. Silva JA, White CJ, Ramee SR, Collins TJ, Jenkins S, Sabet S, Shamaileh Q, Vivekananthan K. “Percutaneous Profundoplasty in the Treatment of Severe Lower Limb Ischemia: Results of Long-term Surveillance ”. J Endovasc Ther 2001;8:75-82.
22. Kuruvanka TS, Mulumudi MS, Vivekananthan K, Francis JF, Delany P, Jaffrani W, Ventura HO. “Patterns of Electrocardiograms in a Multispeciality Clinic: Differences between Primary Care and Cardiology Settings”. Louisiana ACC chapter 2001.
23. Kuruvanka TS, Mulumudi MS, Vivekananthan K, Lavie CJ, Milani RV. “Racial Differences in the Concordance of Stress ECG and Stress Echocardiographic Studies”. Louisiana ACC chapter 2001.
24. Vivekananthan K, Mehra MR, Uber PA, DeGruiter H, Lavie CJ, Milani RV. “Comparison of the Efficacy and Safety of Pravastatin and Simvastatin in Heart Transplantation”. J Assoc Physicians India. 2002 May;50(5):682-4.
25. Harjai KJ, Scott L, Vivekananthan K, Nunez E, Edupuganti R. “The Tei Index: A new Prognostic Index for Patients with Symptomatic Heart Failure”. J Am Soc Echocardiogr. 2002 Sep;15(9):864-8.
26. Vivekananthan K, Kalapura T, Mehra MR, Lavie CJ, Milani RV, Scott RL, Park MH. “Usefulness of the Combined Index of Systolic and Diastolic Myocardial Performance to Identify Cardiac Allograft Rejection”. Am J Cardiol. 2002 Sep 1;90(5):517-20.
27. Mehra MR, Uber PA, Vivekananthan K, Solis S, Scott RL, Park MH, Milani RV, Lavie CJ. “Comparative beneficial effects of simvastatin and pravastatin on cardiac allograft rejection and survival”. J Am Coll Cardiol. 2002 Nov 6;40(9):1609-14.
28. Vivekananthan K, Kuruvanka T, Quintana H, Ramee S, White CJ, Collins TJ, Jenkins SJ, Felberg R, Dawson R, Mckinley K. “Endovascular Intervention Of Symptomatic Basilar Artery Stenosis: Single Center Experience”. Am J Cardiol 2002;90:(Supp)58H.
29. Milani RV, Lavie CJ, Gilliland YE, Vivekananthan K, Cassidy MM, Bernal JA, Morshedi A. “Pulmonary Artery Systolic Pressure in Echocardiographically Normal Subjects”. J Am Coll Cardiol 2003;Mar 257A.
30. Anzuini A, Chiesa R, Vivekananthan K, Uretsky B, Colombo A, Marganato A, Airoldi F, Rosanio S, Augello B, Birnbaum Y, Magnani G, Esposito G, Melissano G, Moura MR, Briguori C. “Endovascular stenting for stenoses in surgically reconstructed brachiocephalic bypass grafts: immediate and midterm outcomes”. J Endovasc Ther. 2004 Jun;11(3):263-8
31. Allie DE, Hebert CJ, Lirtzman MD, Wyatt CH, Keller VA, Khan MH, Khan MA, Fail PS, Vivekananthan K, Mitran EV, Allie SE, Chaisson G, Stagg SJ III, Allie AA, McElderry MW, Barker EA, Walker CM. “Critical Limb Ischemia: A Global Epidemic. A Critical Analysis of Current Treatment Unmasks the Clinical and Economic Costs of CLI”. EuroIntervention. 2005 May;1(1):75-84.
32. Allie DE, Hebert CJ, Lirtzman MD, Wyatt CH, Keller VA, Khan MH, Khan MA, Fail PS, Vivekananthan K, Allie SE, Mitran EV, Chaisson G, Stagg SJ III, Allie AA, McElderry MW, Barker EA, Walker CM. “A safety and feasibility report of combined direct thrombin and GP IIb/IIIa inhibition with bivalirudin and tirofiban in peripheral vascular disease intervention: treating critical limb ischemia like acute coronary syndrome”. J Invasive Cardiol. 2005 Aug;17(8):427-32.
33. Allie DE, Hebert CJ, Lirtzman MD, Wyatt CH, Keller VA, Khan MA, Fail PS, Vivekananthan K, Allie SE, Mitran EV, Chaisson G, Stagg SJ III, Allie AA, McElderry MW, Barker EA, Walker CM. “Plaque Excision in “Real World” Superficial Femoral Artery Disease: 12-Month Clinical and Angiographic Follow-up”. Am J Cardiol 2005;96(Supp)19H.
34. Allie DE, Hebert CJ, Lirtzman MD, Wyatt CH, Keller VA, Khan MA, Fail PS, Vivekananthan K, Allie SE, Mitran EV, Chaisson G, Stagg SJ III, Allie AA, McElderry MW, Barker EA, Walker CM. “Nitinol Stent Fractures: Benign? or Malignant? Angiographic and Fluoroscopic Follow-up in 110 Superficial Femoral Artery Stents”. Am J Cardiol 2005;96(Supp)34H.
35. Allie DE, Hebert CJ, Lirtzman MD, Wyatt CH, Keller VA, Khan MA, Fail PS, Vivekananthan K, Allie SE, Mitran EV, Chaisson G, Stagg SJ III, Allie AA, McElderry MW, Barker EA, Reaven N, Walker CM. “Contemporary Treatment for Critical Limb Ischemia: A Critical Analysis Identifies a “Pathway to Amputation” Not a “Pathway to Salvage”. New Cardiovascular Horizons. Oct 2005.
36. Allie DE, Hebert CJ, Lirtzman MD, Wyatt CH, Keller VA, Vivekananthan K, Allie SE, Mitran EV, Allie AA, McElderry MW, Barker EA, Walker CM. “Adjunctive Bioengineered Bi-layered Cell Therapy (Apligraf) With Excimer Laser Revascularization Improves Wound Healing and Limb Salvage in Critical Limb Ischemia”. Vascular Disease Management. 2006 Jan/Feb;3(1):185-192.
37. Allie DE, Hebert CJ, Lirtzman MD, Wyatt CH, Keller VA, Fail PS, Vivekananthan K, Allie SE, Mitran EV, Chaisson G, Stagg SJ III, Allie AA, McElderry MW, Barker EA, Hebert J, Laurich G, Broussard K, Ladd W, Abben R, Walker CM. “Lower contrast volumes with minor protocol changes enhance 64-channel CTA imaging in peripheral vascular disease”. Cardiovascular Revascularization Medicine. 2006 Apr-Jun;7(2):113-114.
38. Allie DE, Hebert CJ, Lirtzman MD, Wyatt CH, Keller VA, McElderry MW Fail PS, Chaisson G, Vivekananthan K, Mitran EV, Allie AA, Walker CM. The Boomerang Wire vascular access management system: safety and feasibility in the “real world” while “leaving nothing behind”. Cardiovascular Revascularization Medicine. 2006 Apr-Jun;7(2):126.
39. Allie DE, Hebert CJ, Lirtzman MD, Wyatt CH, Keller VA, Mitran EV, Allie AA, McElderry MW, Vivekananthan K, Walker CM. “Targeted renal therapy: early safety and feasibility with a novel treatment for chronic renal insufficiency and contrast induced nephropathy”. Cardiovascular Revascularisation Medicine. 2006 Apr-Jun;7(2):114.
40. Allie DE, Hebert CJ, Lirtzman MD, Wyatt CH, Keller VA, Fail PS, Vivekananthan K, Allie SE, Mitran EV, Chaisson G, Stagg SJ III, Allie AA, McElderry MW, Barker EA, Hebert J, Laurich G, Broussard K, Ladd W, Abben R, Walker CM. “64-Channel multidetector computed tomography angiography in non-cardiac vascular disease: a validation study in the treatment of femoral, popliteal, and infrapopliteal disease”. Cardiovascular Revascularization Medicine. 2006 Apr-Jun;7(2):113.
41. Allie DE, Ramaiah VG, Smalling RG, Hebert CJ, Lirtzman MD, Wyatt CH, Keller AV, McElderry MW, Patlola R, Vivekananthan K, Rodriguez-Lopez JA, Hughes J, Palit T, Merritt RF, Walker CM. “Vascular Access Management in Peripheral Vascular Disease: Results of Multiple Site Boomerang 610 Safety and Feasibility Registry in 232 Peripheral Vascular Interventions”. Abstract. New Cardiovascular Horizons 2007.
Textbook Chapter
1. Vivekananthan K, Lavie CJ, Milani RV. “Stress Testing”. Clinics Atlas of Office Procedures – Cardiovascular Disease. Philadelphia, Pa. WB Saunders Co; 2000:377-391.
 
 

Home Developed and Maintained by AcuTech Solutions  Check E-Mail